Long-term Efficacy and Safety of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results From a Phase III

Hermine Brunner, Nicolino Ruperto, Pierre Quartier, Tamas Constantin, Ekaterina Alexeeva, Isabelle Kone-Paut, Katherine Marzan, Nico Wulffraat, Rayfel Schneider, Shai Padeh, Vyacheslav Chasnyk, Carine Wouters, Jasmin B. Kuemmerle-Deschner, Tilmann Kallinich, Bernard Lauwerys, Elie Haddad, Evgeny L. Nasonov, Maria Trachana, Olga Vougiouka, Karolynn LeonEleni Vritzali, Karine Lheritier, Alberto Martini, Daniel Lovell

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)64-66
JournalArthritis & Rheumatology
Volume69
Publication statusPublished - Apr 2017

Cite this